The purpose of this introductory course for standard practices is to equip the participants representing the biomanufacturing workforce from LMICs with essential skills required to operate according to current good practices. This course will be conducted in-person over three weeks and will include didactic and practice sessions on Good Laboratory Practice, Good Clinical Practice, Good Clinical Laboratory Practice, Good Manufacturing Practice, and biosafety. The course is targeting technicians, engineers or managers employed by an entity formally registered in LMICs and currently involved in the production of bioproducts including vaccines, therapeutics, monoclonal antibodies, etc.
However, due to the restricted number of attendees (120), priorities will be given to 1) manufacturers identified as recipients of mRNA technology from the technology transfer initiative led by WHO and COVAX and 2) participants from LMICs.
Support awarded are not transferrable from one individual to another or from one session to another. Participants must be committed to return to their home institution after completion of the training. Participants will have to demonstrate in their application how the experience gained during the training program will be applied upon return to their home organization.